SXTP Drops 34% in Snapshot as Warrant Deal Raises Dilution Questions
60 Degrees Pharmaceuticals disclosed a discounted warrant exercise agreement. Explore the new financing, additional warrants and risks behind the SXTP decline.
Read the story
60 Degrees Pharmaceuticals disclosed a discounted warrant exercise agreement. Explore the new financing, additional warrants and risks behind the SXTP decline.
Read the story
Starling Oncology sold off after its quarterly update. Examine the mixed guidance changes and why stronger revenue does not settle the stock's valuation.

CVRx reduced its revenue outlook amid payer and sales-execution problems. Examine the confirmed news, analyst downgrades and risks behind the decline.

AirSculpt lowered its annual outlook after weaker procedure demand. Explore the earnings catalyst, refinancing and risks behind the AIRS selloff.

indie Semiconductor rallied after higher sales and an upbeat revenue outlook. Explore the catalyst, GAAP losses and the next tests for profitability.

Senstar’s quarterly sales and profit supported a sharp SNT rally. Explore the earnings catalyst, margin questions and tests for a lasting improvement.

STAK rallied after a preliminary generator agreement. Explore the potential opportunity, contract conditions and milestones needed before revenue follows.

Clean Energy raised its annual adjusted EBITDA outlook, with higher RNG volumes and tax-credit benefits supporting results. An $8.3 million catch-up complicates the quarterly run rate.

VisionSys disclosed a completed financing, but ordinary-share pricing, ADS conversion and dilution are essential to interpreting the headline.

Gogo's loan extension and decade-long spectrum renewal offer concrete catalysts, while Galileo adoption must translate into stronger overall financial results.

Erayak's manufacturing and hybrid-power update provides a concrete catalyst, while commercial launches, margins and cash conversion remain the next tests.

SunCar's preliminary nine-month profit forecast and new repurchase authorization provide two concrete catalysts, with cash conversion and buyback execution still to prove.